about
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaEffects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.Brain swelling and ischaemia in Kenyans with cerebral malariaFactors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children.Risk factors for Plasmodium falciparum hyperparasitaemia in malarious childrenRapid detection of lactate dehydrogenase and genotyping of Plasmodium falciparum in saliva of children with acute uncomplicated malariaUse of area under the curve to evaluate the effects of antimalarial drugs on malaria-associated anemia after treatment.Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.Pharmacokinetics of quinine in African children suffering from kwashiorkor.Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquineTherapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from NigeriaActivities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in childrenTemporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genesPlasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine.Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.Population structure of Plasmodium falciparum gametocyte sex ratios in malarious children in an endemic area.Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome.Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatmentsConfirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas.The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor.Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.Malaria in Nigeria: a revisit.[NANP]19-5.1. A malaria vaccine field trial in Nigerian children.Leukocyte counts in falciparum malaria in African children from an endemic area.Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs.Herpes simplex labialis in children with acute falciparum malaria.Congenital malaria in a hyperendemic area: a revisit.A simple dose regimen of artesunate and amodiaquine based on arm span- or age range for childhood falciparum malaria: a preliminary evaluation.Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria.A simple dose regimen of artesunate and amodiaquine based on age or body weight range for uncomplicated falciparum malaria in children: comparison of therapeutic efficacy with standard dose regimen of artesunate and amodiaquine and artemether-lumefTherapeutic efficacy of artesunate-amodiaquine combinations and the plasma and saliva concentrations of desethylamodiaquine in children with acute uncomplicated Plasmodium falciparum malaria.Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria.Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children.
P50
Q21143739-2E008869-035D-43E6-B234-AACE8CAB0A68Q33587420-29E79532-A406-434F-8BE9-A13D1DEC54D6Q33624500-0AAF56FA-43EA-4CF4-99CF-5B6BA5A051D6Q33711891-86A272A5-B9BF-41EA-84A1-8E7B402CE268Q34044042-ACC50895-4B47-4F75-98DB-AE4914D39BEFQ34087300-9B9E468C-069D-4E77-9F2B-CD343C8A58F5Q34284211-8E291971-7AB6-41DF-B1BB-709842E44C71Q34347670-56F3DA03-DBAD-4D5B-B793-E38F020D4D2DQ34397610-2D2FEB8D-ECD7-4C74-9B1A-B817DBF1A5BFQ34496205-45EB745B-4354-4514-8C8C-1DE50F657974Q34506787-41A827C9-A40E-40C4-A47B-A57EB963086DQ35031900-0455F1D3-E2DC-408D-A2CC-C6FD25CA9C18Q35154559-15EB0A9A-3751-44BF-B748-6198CAFA71D6Q35545461-8779CBFB-0335-4609-AC3B-BBCF6451FF8FQ35759098-D284DD41-EFEB-475D-8891-06EAE5759927Q35821563-B50B21B5-7054-4513-A7A6-D3B1E7124412Q36035590-78178F53-5D78-4E8B-B71A-CEAC26B8AC36Q36265393-DB6135D9-5DB0-4A1A-B074-390A2993D7ADQ36376217-55327D5A-3251-4427-9D46-1186EAA38523Q36889810-32FAA17C-72F8-4E36-9FC6-2E059B0F976DQ37067888-57F0458D-2905-4558-8D4A-25B6783CD3AFQ37434808-A8E4855E-C417-4FCD-91B5-4A133507C137Q37445582-6ADB8185-96AA-4828-B9E2-71CED8AC68A9Q37628066-1EB22914-BBE1-4C1B-BA7D-97F164816E8EQ38470818-83D5E19B-7903-497C-9E15-212BCCF8991EQ38860225-C9DE2FAB-D9E7-46D8-8BA9-569C40D2F055Q38865244-16FB0F9A-EDC9-4BDA-B113-89C82711AFC4Q38870092-F26C8CDD-B636-489B-879F-6476C61EFCC6Q39263957-4C3E2736-A9F0-4C18-BBE9-F5911B678012Q39388141-446EFC83-86DD-44A5-B30D-627886D55F7BQ39423606-ED7DBBF8-0A68-45D8-BD52-70578F0462A5Q39481820-54B4A3AF-7DC8-407B-9A5E-CE6135EB15DBQ39481828-9ABB3F52-15CA-430C-9651-D18EF03D84FFQ39586038-D0D4A591-1777-4909-A426-EA663A91042CQ40306899-598EE5A2-E71C-4325-A03A-58EA0E5D5204Q40326153-8D0C7EE5-770A-4A30-B315-6D7279DDAAB1Q40326964-1DBA55CD-3984-4409-8B25-A93D72C47D18Q40339593-2FEAC5CF-B1FB-4D25-A7B8-D8FD93A30F46Q40372069-FA31D075-EC4F-4D49-AAAD-C42C9D1ABE2BQ40375300-6DA4E9AE-0D21-4115-A915-E1123D461595
P50
description
malaria researcher
@en
name
Akintunde Sowunmi
@en
Akintunde Sowunmi
@nl
type
label
Akintunde Sowunmi
@en
Akintunde Sowunmi
@nl
altLabel
A Sowunmi
@en
A. Sowunmi
@en
Sowunmi A
@en
Sowunmi A.
@en
Sowunmi
@en
prefLabel
Akintunde Sowunmi
@en
Akintunde Sowunmi
@nl